Headlines about Cogentix Medical (NASDAQ:CGNT) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cogentix Medical earned a media sentiment score of 0.06 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 46.1006913638891 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Cogentix Medical (CGNT) opened at 2.49 on Wednesday. The company’s market capitalization is $151.68 million. The company has a 50 day moving average price of $2.19 and a 200-day moving average price of $1.88. Cogentix Medical has a one year low of $1.37 and a one year high of $2.99.
Cogentix Medical (NASDAQ:CGNT) last issued its quarterly earnings results on Tuesday, August 1st. The medical device company reported $0.01 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.01) by $0.02. The company had revenue of $14.06 million for the quarter, compared to analysts’ expectations of $13.90 million. Cogentix Medical had a negative return on equity of 13.83% and a negative net margin of 35.88%. Analysts expect that Cogentix Medical will post ($0.03) EPS for the current fiscal year.
Separately, Zacks Investment Research upgraded Cogentix Medical from a “hold” rating to a “buy” rating and set a $2.50 target price on the stock in a report on Friday, August 4th.
TRADEMARK VIOLATION NOTICE: “Cogentix Medical (CGNT) Receiving Somewhat Favorable News Coverage, Study Shows” was first posted by Stock Observer and is the sole property of of Stock Observer. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.thestockobserver.com/2017/09/13/cogentix-medical-cgnt-receiving-somewhat-favorable-news-coverage-study-shows.html.
Cogentix Medical Company Profile
Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).
Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.